Oxford scientists: these are the final steps we’re taking to get our coronavirus vaccine approved
09 September 2020 - 06:00
Of the hundreds of potential Covid-19 vaccines in development, six are in the final stages of testing, known as phase three clinical trials. One of these — ChAdOx1 nCoV-19 — is the vaccine we’re developing at the University of Oxford.
To be approved, vaccines need to go through multiple rounds of testing to show that they’re safe and effective. A combined phase one and phase two trial of the Oxford vaccine has demonstrated that it is safe — with only short-term side-effects and no serious unexpected events reported — and that it elicits an immune response...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.